# Precision Medicine Guided Treatment for Cancer Pain

> **NCT02664350** · NA · COMPLETED · sponsor: **University of Florida** · enrollment: 63 (actual)

## Conditions studied

- Pain
- CYP2D6 Polymorphism

## Interventions

- **GENETIC:** CYP2D6
- **BEHAVIORAL:** Brief Pain Inventory-Short Form (BPI-SF)
- **BEHAVIORAL:** M.D. Anderson Symptom Inventory (MDASI)
- **GENETIC:** OPRM1

## Key facts

- **NCT ID:** NCT02664350
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-01-10
- **Final completion:** 2019-01-10
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2019-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02664350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02664350, "Precision Medicine Guided Treatment for Cancer Pain". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02664350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*